𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Karyotype at relapse following allogeneic bone marrow transplantation for chronic myelogenous leukemia

✍ Scribed by Nandita K. Shah; John Wagner; George Santos; Constance A. Griffin


Book ID
119105343
Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
836 KB
Volume
61
Category
Article
ISSN
0165-4608

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Very late relapse of chronic myelogenous
✍ Arunabh Sekhri; Delong Liu; Muhammad Rasul; Nasir Ahmed; Tauseef Ahmed; Karen Se πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 99 KB

Allogeneic stem cell transplantation is considered to be a curative treatment modality in patients with chronic myelogenous leukemia. However patients are at risk for relapse years after transplantation. Currently we present two patients who relapsed 16 and 24 years after allogeneic bone marrow tran

Extra-medullary relapse of leukemia foll
✍ W. Y. Au; Y. L. Kwong; A. K. W. Lie; S. K. Ma; R. Liang πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 208 KB πŸ‘ 2 views

The curative effect of allogeneic bone marrow transplantation (BMT) for acute and chronic leukemia is attributed to the intensive conditioning chemotherapy with or without radiotherapy, as well as an immune-mediated graft versus leukemia (GVL) effect. A different pattern of relapse has been observed